Skip to main content

Sangyong Jon

Korea Advanced Institute of Science and Technology · Biochemistry, Genetics and Molecular Biology

About the Lab

Professor Sangyong Jon's research lab specializes in the design and development of advanced nanomaterials for targeted theranostics and drug delivery, with a strong focus on cancer and inflammatory diseases. The lab integrates nanotechnology, bioconjugation, and molecular targeting to create smart nanoparticles that enable simultaneous diagnosis (e.g., via MRI) and therapy (e.g., drug delivery or immunostimulation). Key innovations include aptamer-conjugated nanoparticles, PEGylated natural compound-based nanotherapeutics, and multifunctional platforms for imaging and immune modulation. The lab’s work emphasizes improving the solubility, stability, and bioavailability of bioactive molecules while ensuring high specificity and efficacy in preclinical models.

nanotheranosticstargeted drug deliveryPEGylationinflammatory disease therapyaptamer-conjugated nanoparticles

Research Overview

Papers
286
Total Citations
20,325
Papers (5y)
47
Primary Field
Biochemistry, Genetics and Molecular Biology

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
47total
2022
2023
2024
2025
2026
Citations per year (5y)
452total
20222023202420252026

Selected Papers

15
1
Article|1,027 citations·2007
Quantum Dot−Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer
Vaishali Bagalkot, Liangfang Zhang, Etgar Levy‐Nissenbaum, Sangyong Jon, Philip W. Kantoff, Róbert Langer, Omid C. Farokhzad
SJR Q1Nano Letters

We report a novel quantum dot (QD)-aptamer(Apt)-doxorubicin (Dox) conjugate [QD-Apt(Dox)] as a targeted cancer imaging, therapy, and sensing system. By functionalizing the surface of fluorescent QD with the A10 RNA aptamer, which recognizes the extracellular domain of the prostate specific membrane antigen (PSMA), we developed a targeted QD imaging system (QD-Apt) that is capable of differential uptake and imaging of prostate cancer cells that express the PSMA protein. The intercalation of Dox,

Molecular BiologyBiochemistry, Genetics and Molecular Biology
2
Article|720 citations·2010
A Drug-Loaded Aptamer−Gold Nanoparticle Bioconjugate for Combined CT Imaging and Therapy of Prostate Cancer
Dongkyu Kim, Yong Yeon Jeong, Sangyong Jon
SJR Q1ACS Nano

Computed tomography (CT) is one of the most useful diagnostic tools among commonly used biomedical imaging techniques, which also include magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound. However, currently available CT contrast agents, which are based on small iodinated molecules, possess a number of limitations, including a lack of targeted molecular imaging, short imaging time, and renal toxicity. Here, we report a multifunctional nanoparticle for targeted

Molecular BiologyBiochemistry, Genetics and Molecular Biology
3
Article|611 citations·2006
An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug‐Delivery Platform
Vaishali Bagalkot, Omid C. Farokhzad, Róbert Langer, Sangyong Jon
SJR Q1Angewandte Chemie International Edition

Trojan aptamer: A novel strategy for targeted drug delivery to cancer cells was developed through the formation of a physical conjugate (see scheme) between doxorubicin (Dox) and the A10 RNA aptamer that binds to the prostate-specific membrane antigen (PSMA). The aptamer–Dox conjugate could efficiently bind to PSMA-expressing cells, thereby resulting in its uptake and the intracellular release of Dox.

Molecular BiologyBiochemistry, Genetics and Molecular Biology
4
Article|529 citations·2014
Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy
Vipul Gujrati, Sung-Hyun Kim, Sang‐Hyun Kim, Jung Joon Min, Hyon E. Choy, Sun Chang Kim, Sangyong Jon
SJR Q1ACS Nano

Advances in genetic engineering tools have contributed to the development of strategies for utilizing biologically derived vesicles as nanomedicines for achieving cell-specific drug delivery. Here, we describe bioengineered bacterial outer membrane vesicles (OMVs) with low immunogenicity that can target and kill cancer cells in a cell-specific manner by delivering small interfering RNA (siRNA) targeting kinesin spindle protein (KSP). A mutant Escherichia coli strain that exhibits reduced endotox

EcologyEnvironmental Science
5
Article|238 citations·2016
Bilirubin Nanoparticles as a Nanomedicine for Anti‐inflammation Therapy
Yonghyun Lee, Hyungjun Kim, Sukmo Kang, Jinju Lee, Jinho Park, Sangyong Jon
SJR Q1Angewandte Chemie International Edition

Despite the high potency of bilirubin as an endogenous anti-inflammatory compound, its clinical translation has been hampered because of its insolubility in water. Bilirubin-based nanoparticles that may overcome this critical issue are presented. A polyethylene glycol compound (PEG) was covalently attached to bilirubin, yielding PEGylated bilirubin (PEG-BR). The PEG-BR self-assembled into nanoscale particles with a size of approximately 110 nm, termed bilirubin nanoparticles (BRNPs). BRNPs are h

Molecular BiologyBiochemistry, Genetics and Molecular Biology
6
Article|223 citations·2011
Image‐Guided Prostate Cancer Therapy Using Aptamer‐Functionalized Thermally Cross‐Linked Superparamagnetic Iron Oxide Nanoparticles
Mi Kyung Yu, Dongkyu Kim, In‐Hyun Lee, Jee‐Soo So, Yong Yeon Jeong, Sangyong Jon
SJR Q1Small

CG-rich duplex containing prostate-specific membrane antigen (PSMA) aptamer-conjugated thermally cross-linked superparamagnetic iron oxide nanoparticles (TCL-SPIONs) is reported as prostate cancer-specific nanotheranostic agents. These agents are capable of prostate tumor detection in vivo by magnetic resonance imaging (MRI) and selective delivery of drugs to the tumor tissue, simultaneously. The prepared PSMA-functionalized TCL-SPION via a hybridization method (Apt-hybr-TCL-SPION) exhibited pre

BiomaterialsMaterials Science
7
Article|204 citations·2020
Nanoparticles Derived from the Natural Antioxidant Rosmarinic Acid Ameliorate Acute Inflammatory Bowel Disease
Chan Ho Chung, Wonsik Jung, Hyeongseop Keum, Tae Woo Kim, Sangyong Jon
SJR Q1ACS Nano

Rosmarinic acid (RA), one of the most important polyphenol-based antioxidants, has received growing interest because of its bioactive properties, including anti-inflammatory, anticancer, and antibacterial activities. Despite the high therapeutic potential of RA, its intrinsic properties of poor water solubility and low bioavailability have limited its translation into the clinic. Here, we report on the synthesis and preparation of PEGylated RA-derived nanoparticles (RANPs) and their use as a the

GeneticsBiochemistry, Genetics and Molecular Biology
8
Article|193 citations·2012
Imageable Antigen‐Presenting Gold Nanoparticle Vaccines for Effective Cancer Immunotherapy In Vivo
In‐Hyun Lee, Ho‐Keun Kwon, Sukyung An, Daejin Kim, Sunghyun Kim, Mi Kyung Yu, Jae‐Hyuk Lee, Tae Sup Lee, Sin‐Hyeog Im, Sangyong Jon
SJR Q1Angewandte Chemie International EditionOA

Delivery tracking: Goldnanoparticles (AuNPs) were functionalized with a red fluorescent protein (RFP, pink shapes in picture) as model antigen and an oligonucleotide (CpG) that stimulates the immune response. These functionalized AuNPs were used as cancer vaccines in a tumor model, where they enabled efficient delivery of an antigen to target sites, tracking of the vaccines using noninvasive clinical imaging, and cancer prevention and therapy. Vaccination with the aid of adjuvants is a highly ef

ImmunologyImmunology and Microbiology
9
Article|152 citations·2017
Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses
Sukmo Kang, Sukyung Ahn, Jeewon Lee, Jin Yong Kim, Minsuk Choi, Vipul Gujrati, Hyungjun Kim, Jinjoo Kim, Eui‐Cheol Shin, Sangyong Jon
SJR Q1Journal of Controlled Release
ImmunologyImmunology and Microbiology
10
Article|152 citations·2008
Conjugated Chitosan as a Novel Platform for Oral Delivery of Paclitaxel
Eun Hye Lee, Jinju Lee, In‐Hyun Lee, Mikyung Yu, Hyungjun Kim, Su Young Chae, Sangyong Jon
SJR Q1Journal of Medicinal Chemistry

A new platform for oral delivery of paclitaxel (PTX) was developed through chemical conjugation of PTX to a low molecular weight chitosan (LMWC). The LMWC-PTX conjugate contained approximately 12 wt % PTX and showed greatly enhanced water solubility (>1 mg/mL) as compared to native PTX. The conjugate showed comparable IC 50 values to that of the parent PTX against human cancer cell lines. The pharmacokinetic data revealed approximately 42% of bioavailability after oral administration of 5 mg PTX

BiomaterialsMaterials Science
11
Article|141 citations·2009
In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration
Eun Hye Lee, Hyungjun Kim, In‐Hyun Lee, Sangyong Jon
SJR Q1Journal of Controlled Release
BiomaterialsMaterials Science
12
Article|132 citations·2017
Bilirubin nanoparticle preconditioning protects against hepatic ischemia-reperfusion injury
Jin Yong Kim, Dong Yun Lee, Sukmo Kang, Wenjun Miao, Hyungjun Kim, Yonghyun Lee, Sangyong Jon
SJR Q1Biomaterials
Molecular BiologyBiochemistry, Genetics and Molecular Biology
13
Article|126 citations·2003
Construction of Nonbiofouling Surfaces by Polymeric Self-Assembled Monolayers
Sangyong Jon, Jiehyun Seong, Ali Khademhosseini, Thanh-Nga Tran, Paul E. Laibinis, Róbert Langer
SJR Q1Langmuir

The synthesis of a poly(ethylene glycol) (PEG)-grafted surface-reactive random copolymer and its self-assembled structure on Si/SiO 2 substrates for construction of nonbiofouling surfaces are reported. The copolymer, poly(TMSMA-r-PEGMA), which is comprised of an “anchor part” (trimethoxysilane) and a “function part” (PEG), was synthesized by a radical polymerization reaction. The copolymer spontaneously formed monolayers on Si/SiO 2 wafers with average thicknesses of 11 Å. Tapping mode atomic fo

Surfaces, Coatings and FilmsMaterials Science
14
Article|125 citations·2009
Carbon Nanosyringe Array as a Platform for Intracellular Delivery
Sang-Jin Park, Youn-Su Kim, Won Bae Kim, Sangyong Jon
SJR Q1Nano Letters

We report a novel platform for intracellular delivery of genetic material and nanoparticles, based on vertically aligned carbon nanosyringe arrays (CNSAs) of controllable height. Using this technology, we have shown that plasmid and quantum dots can be efficiently delivered to the cytoplasm of cancer cells and human mesenchymal stem cells. The CNSA platform holds great promise for a myriad of applications including cell-based therapy, imaging, and tracking in vivo, and in biological studies aime

Molecular BiologyBiochemistry, Genetics and Molecular Biology
15
Article|124 citations·2011
Targeted chemoimmunotherapy using drug-loaded aptamer–dendrimer bioconjugates
In‐Hyun Lee, Sukyung An, Mi Kyung Yu, Ho‐Keun Kwon, Sin‐Hyeog Im, Sangyong Jon
SJR Q1Journal of Controlled Release
Molecular BiologyBiochemistry, Genetics and Molecular Biology

Research Areas

Molecular BiologyBiomaterialsBiomedical EngineeringRadiology, Nuclear Medicine and ImagingImmunologyOncology

Dive deeper into Sangyong Jon's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.